Monographie - Valproic acid - Stabilis 4.0

Poslední aktualizace :
06/05/2024

Priešepilepsinis vaistas

Valproic acid

Įpurškimas

Tirpalų stabilumas

Mišinių stabilumas

Stabilumą lemiantys veiksniai

Suderinamumas

Leidimo būdai

Bibliografija

Pdf

Cheminė sandara

Prekinis pavadinimas

Prekinis pavadinimas

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Acido valproico	Ispanija
Convulex	Iranas
Depacon	Jungtinės Amerikos Valstijos
Depakene	Meksikas
Depakin	Italija
Depakine	Belgija, Graikija, Iranas, Ispanija, Jungtiniai Arabų Emyratai, Lenkija, Liuksemburgas, Olandija, Portugalija, Saudo Arabija, Šveicarija, Vengrija
Depalept	Egiptas
Deprakine	Suomija
Diplexil	Portugalija
Epilim	Airija, Didžioji Britanija, Malaizija, Naujojoje Zelandijoje
Episenta	Didžioji Britanija
Ergenyl	Švedija, Vokietija
Milzone	Ispanija
Orfiril	Airija, Danija, Iranas, Norvegija, Olandija, Suomija, Švedija, Šveicarija, Vokietija
Orlept	Iranas
Valcote	Argentina, Čilė, Kolumbija, Venesuela
Valprax	Peru
Valproate Mylan	Belgija
Valproate sodium	Jungtinės Amerikos Valstijos

Bibliografija

Įpurškimas

Bibliografija : Valproic acid

	Tipas	Leidinys
1508	Žurnalas	Voirol P, Berger-Gryllaki M, Pannatier A, Eggimann P, Sadeghipour F. Visual compatibility of insulin aspart with intravenous drugs frequently used in ICU. EJHP 2015 ;22:123-124.
1759	Žurnalas	Servais H, Tulkens PM. Stability and compatibility of ceftazidime administered by continuous infusion to intensive care patients. Antimicrob Agents Chemother 2001 ; 45: 2643-2647.
2141	Žurnalas	Barinian N, Chanteux H, Viaene E, Servais H, Tulkens PM. Stability and compatibility study of cefepime in comparaison with ceftazidime for potential administration by continuous infusion under conditions pertinent to ambulatory treatment of cystic fibrosis patients and to administration in intensive care units. J Antimicrob Chemother 2003 ; 51: 651-658.
2231	Žurnalas	de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S. Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection. J Antimicrob Chemother 2008 ; 61, 2: 382-388.
3012	Žurnalas	Sullivan T, Forrest J.M, Leclair G. Compatibility of Cloxacillin Sodium with Selected Intravenous Drugs During Simulated Y-Site Administration Hosp Pharm 2015 ; 50, 3: 214-220.
3385	Žurnalas	Raverdi V, Ampe E, Hecq JD, Tulkens PM. Stability and compatibility of vancomycin for administration by continuous infusion. J Antimicrob Chemother 2013 ; 68: 1179-1182.
3408	Žurnalas	Tollec S, Touzin K, Pelletier E, Forest J.M. Evaluation visuelle de la compatibilité physique de la naloxone avec d’autres médicaments intraveineux usuels. Pharmactuel 2013 ; 46, 1 : 16-21.
3823	Žurnalas	Juan E.P, Palau M.M, Cerd? S.A, Rubert M.A, Nicolau B.R. Compatibilité physique de médicaments administrés dans l’unité de soins intensifs Pharmactuel 2015 ; 48, 3 : 146-152.
3942	Žurnalas	Frank M.I, Boddu S.H.S, . Mauro V.F,. Churchwell M.D. Physical compatibility of valproate sodium injection with dobutamine and dopamine. Am J Health-Syst Pharm 2017 ; 74, 5: 280-281.
4319	Žurnalas	Lessard J-J, Caron E, Schérer H, Forest J-M, Leclair G. Compatibility of Y-site Injection of Meropenem Trihydrate With 101 Other Injectable Drugs. Hosp Pharm 2020 ; 55, 5: 332-337.
4389	Žurnalas	Côté K, Correal F, Metras M.E, Friciu M, Forest J.M, Leclair G. Compatibilité physique des médicaments administrés en Y aux soins intensifs, en particulier la dexmédétomidine, le lévosimendan et la kétamine. Pharmactuel 2019 ;52,4:206-213
4428	Žurnalas	Rashed S.M, Sweatman T.W, Thoma L, Hovinga C.A, Phelps S.J. Chemical Compatibility of Depacon® with Medications Frequently Administered by Intravenous Y-Site Delivery in Patients with Epilepsy or Head Trauma. J Pediatr Pharmacol Ther 2004 ; 9, 2: 126-132.

Mentions Légales